Omnicell
OMCL
174 hedge funds and large institutions have $947M invested in Omnicell in 2014 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 59 increasing their positions, 72 reducing their positions, and 16 closing their positions.
19% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 16
12% more capital invested
Capital invested by funds: $847M → $947M (+$100M)
0% more funds holding
Funds holding: 174 → 174 (0)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
18% less repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 72
45% less call options, than puts
Call options by funds: $281K | Put options by funds: $509K
Top Buyers
Top Sellers
OMCL Hedge Fund Activity: Q1 2014 in Review
174 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Omnicell (OMCL) for Q1 2014, worth a combined $947M — up 12% from $847M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new OMCL positions and 16 closed out — a net gain of 3 holders — while 59 added to existing stakes and 72 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $9.57M. The largest seller was JP Morgan Chase, cutting an estimated $8.55M.
- 174 institutional investors held Omnicell (OMCL) as of Q1 2014, unchanged from Q4 2013.
- Funds reported $947M of Omnicell stock for Q1 2014, up 12% quarter-over-quarter.
- 19 funds opened new Omnicell positions in Q1 2014 and 16 closed out, a net change of +3 holders.
- The largest Omnicell buyer in Q1 2014 was Fidelity Investments, an estimated $9.57M added.
- The largest Omnicell seller in Q1 2014 was JP Morgan Chase, an estimated $8.55M sold.
Based on aggregated 13F filings for Q1 2014.